Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2012-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b462d68c6b6c1b7b6667c1e3e2dd47aa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59381fe9b6f83d1cb3c273b195532df0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b036d982f830b751faa3a8383259d799 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddf7e50165fb92cd832236ac59886912 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77acd30be3565b1681e1600b3172ac23 |
publicationDate |
2013-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-201328707-A |
titleOfInvention |
HER3 antibody against region II of epidermal growth factor receptor 3 (HER3) |
abstract |
The present invention relates to antibodies or fragments thereof which target the epitope of the HER3 receptor present in domain 2 of the HER3 receptor to block ligand-dependent and non-ligand-dependent signaling and tumor growth ; and its compositions and methods of use. |
priorityDate |
2011-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |